Skip to main content
follow
#main-content
follow
http://www.aasld.org
follow
http://www.idsociety.org/
Table of Contents
follow
/contents
Test, Evaluate, Monitor
follow
/evaluate
Treatment-Naive Patients
follow
/treatment-naive
Treatment-Experienced Patients
follow
/treatment-experienced
Unique & Key Populations
follow
/unique-populations
About the Guidance
follow
/about
Table of Contents
follow
/contents
Introduction
follow
/contents/welcome
Methods
follow
/contents/methods
Methods Table 1
follow
/contents/methods/table-1
Methods Table 2
follow
/contents/methods/table-2
Methods Table 3 Abbreviations
follow
/contents/methods/abbreviations
References
follow
/references
Test, Evaluate, Monitor
follow
/evaluate
Testing and Linkage to Care
follow
/evaluate/testing-and-linkage
When and in Whom
follow
/evaluate/when-whom
Cost, Reimbursement, and Cost-Effectiveness
follow
/evaluate/cost
Monitoring
follow
/evaluate/monitoring
Incomplete Adherence
follow
/evaluate/monitoring/incomplete-adherence
HCV Resistance
follow
/evaluate/resistance
Treatment-Naive
follow
/treatment-naive
Simplified: No Cirrhosis
follow
/treatment-naive/simplified-treatment
Simplified: Comp. Cirrhosis
follow
/treatment-naive/simplified-treatment-compensated-cirrhosis
Decompensated Cirrhosis
follow
/unique-populations/decompensated-cirrhosis
Genotype 1
follow
/treatment-naive/gt1
GT1a: No Cirrhosis
follow
/treatment-naive/gt1a/no-cirrhosis
GT1a: Compensated
follow
/treatment-naive/gt1a/compensated-cirrhosis
GT1b: No Cirrhosis
follow
/treatment-naive/gt1b/no-cirrhosis
GT1b: Compensated
follow
/treatment-naive/gt1b/compensated-cirrhosis
Genotype 2
follow
/treatment-naive/gt2
GT2 : No Cirrhosis
follow
/treatment-naive/gt2/no-cirrhosis
GT2 : Compensated
follow
/treatment-naive/gt2/compensated-cirrhosis
Genotype 3
follow
/treatment-naive/gt3
GT3 : No Cirrhosis
follow
/treatment-naive/gt3/no-cirrhosis
GT3 : Compensated
follow
/treatment-naive/gt3/compensated-cirrhosis
Genotype 4
follow
/treatment-naive/gt4
GT4 : No Cirrhosis
follow
/treatment-naive/gt4/no-cirrhosis
GT4 : Compensated
follow
/treatment-naive/gt4/compensated-cirrhosis
Genotype 5 or 6
follow
/treatment-naive/gt5-6
Treatment-Experienced
follow
/treatment-experienced
SOF-Based and ELB/GRZ Treatment Failures
follow
/treatment-experienced/sof-and-elb-grz-failures
G/P Treatment Failures
follow
/treatment-experienced/g-p-failures
Multiple DAA Treatment Failures
follow
/treatment-experienced/multiple-daa-failure
Decompensated Cirrhosis
follow
/unique-populations/decompensated-cirrhosis
Unique & Key Populations
follow
/unique-populations
HIV/HCV Coinfection
follow
/unique-populations/hiv-hcv
Decompensated Cirrhosis
follow
/unique-populations/decompensated-cirrhosis
Post Liver Transplant
follow
/unique-populations/post-liver-transplant
Organs from HCV-Viremic Donors
follow
/unique-populations/organs-from-hcv-viremic-donors
Renal Impairment
follow
/unique-populations/renal-impairment
Kidney Transplant
follow
/unique-populations/kidney-transplant
Acute Infection
follow
/unique-populations/acute-infection
HCV in Pregnancy
follow
/unique-populations/pregnancy
HCV in Children
follow
/unique-populations/children
PWID, MSM & Corrections
follow
/unique-populations/key
People Who Inject Drugs
follow
/unique-populations/pwid
Men Who Have Sex With Men
follow
/unique-populations/msm
Correctional Settings
follow
/unique-populations/correctional
Announcements
follow
/about/announcements
Organizations
follow
/about/organizations
Panel
follow
/about/panel
Disclosures
follow
/about/disclosures
Process
follow
/about/process
Citing and Permissions
follow
/about/permissions
Survey
follow
/about/survey
Website Policies
follow
/about/policies
Contact
follow
/about/contact
Contents and Introduction - Select a Page
follow
#
Full Table of Contents
follow
/contents
Introduction
follow
/contents/welcome
Methods
follow
/contents/methods
Table 1. Summary of the Process and Methods for the Guidance Development
follow
/contents/methods/table-1
Table 2. Rating System Used to Rate Level of Evidence and Strength of Recommendation
follow
/contents/methods/table-2
Table 3. Commonly Used Abbreviations and Their Expansions
follow
/contents/methods/abbreviations
References
follow
/references
Testing, Evaluation, and Monitoring of Hepatitis C - Browse Topics
follow
#
Testing, Evaluation, and Monitoring of Hepatitis C
follow
/evaluate
HCV Testing and Linkage to Care
follow
/evaluate/testing-and-linkage
When and in Whom to Initiate HCV Therapy
follow
/evaluate/when-whom
Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens
follow
/evaluate/cost
Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
follow
/evaluate/monitoring
HCV Resistance Primer
follow
/evaluate/resistance
Initial Treatment of HCV Infection - Choose Patient Genotype
follow
#
Initial Treatment of HCV Infection
follow
/treatment-naive
Simplified HCV Treatment for Treatment-Naive Patients Without Cirrhosis
follow
/treatment-naive/simplified-treatment
Simplified HCV Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
follow
/treatment-naive/simplified-treatment-compensated-cirrhosis
Treatment-Naive Genotype 1
follow
/treatment-naive/gt1
Treatment-Naive Genotype 2
follow
/treatment-naive/gt2
Treatment-Naive Genotype 3
follow
/treatment-naive/gt3
Treatment-Naive Genotype 4
follow
/treatment-naive/gt4
Treatment-Naive Genotype 5 or 6
follow
/treatment-naive/gt5-6
Retreatment of Persons in Whom Prior Therapy Has Failed
follow
#
Retreatment of Persons in Whom Prior Therapy Has Failed
follow
/treatment-experienced
Sofosbuvir-based and elbasvir/grazoprevir treatment failures
follow
/treatment-experienced/sof-and-elb-grz-failures
Glecaprevir/pibrentasvir treatment failures
follow
/treatment-experienced/g-p-failures
Multiple DAA regimen failures
follow
/treatment-experienced/multiple-daa-failure
Management of Unique & Key Populations - Review Recommendations
follow
#
Management of Unique Populations with HCV Infection
follow
/unique-populations
Patients With HIV/HCV Coinfection
follow
/unique-populations/hiv-hcv
Patients With Decompensated Cirrhosis
follow
/unique-populations/decompensated-cirrhosis
Patients Who Develop Recurrent HCV Infection Post-Liver Transplantation
follow
/unique-populations/post-liver-transplant
Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors
follow
/unique-populations/organs-from-hcv-viremic-donors
Patients With Renal Impairment
follow
/unique-populations/renal-impairment
Kidney Transplant Patients
follow
/unique-populations/kidney-transplant
Management of Acute HCV Infection
follow
/unique-populations/acute-infection
HCV in Pregnancy
follow
/unique-populations/pregnancy
HCV in Children
follow
/unique-populations/children
Management of Key Populations With Chronic HCV Infection
follow
/unique-populations/key
Identification and Management of HCV in People Who Inject Drugs
follow
/unique-populations/pwid
HCV in Key Populations: Men Who Have Sex With Men
follow
/unique-populations/msm
HCV Testing and Treatment in Correctional Settings
follow
/unique-populations/correctional
iPhone / iPad
follow
#tab1
Click here to download the PDF
follow
/sites/default/files/full-guidance-pdf/AASLD-IDSA_HCV-Guidance_TxN-Simplified-Tx-No-Cirr_e.pdf
read more
follow
/treatment-naive/simplified-treatment
Click here to download the PDF
follow
/sites/default/files/full-guidance-pdf/AASLD-IDSA_HCV-Guidance_TxN-Simplified-Tx-Comp-Cirr_e.pdf
read more
follow
/treatment-naive/simplified-treatment-compensated-cirrhosis
Updated Testing Recommendations
follow
/evaluate/testing-and-linkage%20
What’s New, Updates and Changes to the Guidance
follow
/announcements/09292021-0000/what%E2%80%99s-new-updates-and-changes-guidance
What’s New, Updates and Changes to the Guidance
follow
/announcements/03122021-0000/what%E2%80%99s-new-updates-and-changes-guidance
Home
follow
http://www.hcvguidelines.org
Organizations
follow
/about/organizations
Panel
follow
/about/panel
Permissions
follow
/about/permissions
Policies
follow
/about/policies
Survey
follow
/about/survey
Contact
follow
/about/contact